These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6698110

  • 1. Salutary effects of nitrendipine, a new calcium entry blocker, in hemorrhagic shock.
    Hock CE, Su JY, Lefer AM.
    Eur J Pharmacol; 1984 Jan 13; 97(1-2):37-46. PubMed ID: 6698110
    [Abstract] [Full Text] [Related]

  • 2. Beneficial effect of anisodamine in hemorrhagic shock.
    Su J, Hock CE, Lefer AM.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr 13; 325(4):360-5. PubMed ID: 6728045
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effect of arachidonic acid during hemorrhagic shock in the dog.
    Flynn JT, Lefer AM.
    Circ Res; 1977 Apr 13; 40(4):422-8. PubMed ID: 844155
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beneficial action of a new opiate antagonist (Win 44,441-3) in hemorrhagic shock.
    Curtis MT, Lefer AM.
    Eur J Pharmacol; 1982 Mar 12; 78(3):307-13. PubMed ID: 6279411
    [Abstract] [Full Text] [Related]

  • 7. Beneficial actions of nalorphine during hemorrhagic shock in cats.
    Hock CE, Curtis MT, Jaffe JS, Lefer AM.
    Proc Soc Exp Biol Med; 1983 May 12; 173(1):76-81. PubMed ID: 6304745
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock.
    Stahl GL, Bitterman H, Terashita Z, Lefer AM.
    Eur J Pharmacol; 1988 May 10; 149(3):233-40. PubMed ID: 3409951
    [Abstract] [Full Text] [Related]

  • 10. Actions of opiate antagonists with selective receptor interactions in hemorrhagic shock.
    Curtis MT, Lefer AM.
    Circ Shock; 1983 May 10; 10(2):131-45. PubMed ID: 6301706
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of ethylketocyclazocine in hemorrhagic shock.
    Curtis MT, Lefer AM.
    Adv Shock Res; 1983 May 10; 10():101-9. PubMed ID: 6308972
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Salutary effects of prostacyclin in endotoxic shock.
    Lefer AM, Tabas J, Smith EF.
    Pharmacology; 1980 May 10; 21(3):206-12. PubMed ID: 6997895
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lack of effect of thyrotropin releasing hormone (TRH) in circulatory shock.
    Hock CE, Lefer AM.
    Peptides; 1985 May 10; 6(3):547-53. PubMed ID: 3934648
    [Abstract] [Full Text] [Related]

  • 18. Captopril and the intestinal response to hemorrhagic shock.
    Rosenfeld LM, Cooper HS.
    Arch Int Pharmacodyn Ther; 1982 Sep 10; 259(1):144-52. PubMed ID: 6758718
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
    Bitterman H, Smith BA, Lefer AM.
    Circ Shock; 1988 Mar 10; 24(3):159-68. PubMed ID: 3383353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.